![Medtronic PROTECTA XT DR D314DRG Скачать руководство пользователя страница 380](http://html.mh-extra.com/html/medtronic/protecta-xt-dr-d314drg/protecta-xt-dr-d314drg_clinician-manual_1763148380.webp)
Figure 195. VT Therapies screen
1 The label “Off-SM” for Rx1 indicates that Smart Mode cancelled an unsuccessful ATP therapy.
9.3 Treating VT and FVT with ventricular cardioversion
A VT or FVT episode is detected when sustained ventricular tachycardia occurs. Treatments
for these episodes are intended to interrupt the tachyarrhythmia and restore sinus rhythm.
Ventricular ATP therapies may terminate these episodes. If the ATP therapies are
ineffective, a high-voltage shock is required.
9.3.1 System solution: ventricular cardioversion
The device can respond to a VT or FVT episode by delivering ventricular cardioversion
therapy to the patient’s heart. Cardioversion, like defibrillation, is intended to terminate the
episode by simultaneously depolarizing the heart tissue and restoring the patient’s normal
sinus rhythm. However, unlike defibrillation, cardioversion requires that the device
synchronizes the therapy to a sensed ventricular event.
For more information about detecting VT or FVT episodes, refer to Section 8.2, “Detecting
ventricular tachyarrhythmias”, page 304.
Medtronic
PROTECTA™ XT DR D314DRG
380
Clinician Manual
Содержание PROTECTA XT DR D314DRG
Страница 2: ......
Страница 9: ...Index 488 Medtronic PROTECTA XT DR D314DRG Clinician Manual 9 ...
Страница 506: ......
Страница 507: ......